The resistance of some cancers to the cell-killing effects of radiation therapy may be due to abnormalities in the mitochondria – the cellular structures responsible for generating energy, according to an international team of researchers. Their findings are published in the Nov. 25 issue of Developmental Cell.
Maxim Frolov, associate professor of biochemistry and molecular genetics at the University of Illinois at Chicago, and colleagues investigated the effects of a mutation in a gene called E2F, which controls other genes responsible for initiating programmed cell death, a normal function in most cells. Cells undergo programmed cell death—or apoptosis—when they are no longer needed, as a normal part of aging, or in response to environmental factors like radiation that damage cellular DNA.
When Frolov and colleagues exposed fruit flies carrying a mutant E2F gene to radiation, genes that initiate apoptosis were activated, but the flies did not die.
"Something else was preventing the flies from dying, even though the genes needed to undergo cell death were turned on," Frolov said.
A closer look within the cells of the flies revealed that their mitochondria were misshapen and produced less energy than normal mitochondria. Flies with the most severely deranged mitochondria were the most resistant to radiation-induced cell death.
The observation in fruit flies suggested a previously unknown role for the E2F transcription factor—the protein encoded by E2F that regulates expression of other genes—in mitochondrial function.
"It seems their mitochondria were also affected by the E2F mutation and were not functioning at full strength," said Frolov. "You need properly functioning mitochondria to carry out programmed cell death."
Turning to human cells, the researchers found the same effects: those that lacked the E2F gene were resistant to the effects of radiation. Frolov said the similarity in the findings shows that basic cellular functions do not change much across the vast evolutionary distance between fruit flies and humans.
"This result highlights a remarkable degree of conservation between fruit flies and humans and illustrates the advantages of using model organisms in cancer research," said Frolov, whose laboratory is part of the UIC Cancer Center.
Frolov and his colleagues think that dysfunctional mitochondria might underlie the differences in how patients respond to radiation therapy. Previous studies have suggested that the inability of some patients' mitochondria to support apoptosis might account for differences in their response to chemotherapy for acute myelogenous leukemia.
"If we could develop a small-molecule drug that could enhance mitochondrial function in these patients, we may be able to improve the effectiveness of radiation therapy," Frolov said.
Explore further: Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin
Medical Xpress on facebook
Related Stories
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin
Nov 01, 2013
A new study from MIT and the University of Toronto offers a possible way to overcome that resistance. The researchers found that when cisplatin was delivered to cellular structures called mitochondria. DNA ...
Two pathways in the cell interact to spur tumor growth: study
Mar 28, 2011
Inactivation of two pathways that regulate cell division profoundly disrupts cell-cycle control and leads to tumor growth, according to researchers from the University of Illinois at Chicago College of Medicine.
How mitochondrial DNA defects cause inherited deafness
Feb 17, 2012
(Medical Xpress) -- Yale scientists have discovered the molecular pathway by which maternally inherited deafness appears to occur: Mitochondrial DNA mutations trigger a signaling cascade, resulting in programmed ...
'Jekyll-and-Hyde' protein offers a new route to cancer drugs
Sep 26, 2013
The mood changes of a 'Jekyll-and-Hyde' protein, which sometimes boosts tumour cell growth and at other times suppresses it, have been explained in a new study led by Oxford University researchers.
Mitochondrial cooperatives
Aug 13, 2013
Mitochondria, the organelles that supply the cell with energy, are highly dynamic and can link up to form complex tubular networks. A new study shows that this response can transiently compensate for a shortfall in energy ...
Recommended for you
Co-transplanted cells and treadmill training aids rats with spinal cord injury
14 minutes ago
After Schwann cells (SCs), the principal cells in the peripheral nervous system, and olfactory ensheathing cells (OECs), cells that ensheath the non-myelinated peripheral neurons in the nose, were co-transplanted into laboratory ...
Study shows marijuana's potential for treating autoimmune disorders
16 minutes ago
A new study from researchers at the University of South Carolina provides evidence that THC (tetrahydrocannabinol), a principal ingredient in marijuana, may be beneficial in treating those with autoimmune disorders.
EPC secreted factors favorably impact on pancreatic islet cell cotransplantation
17 minutes ago
Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted. Researchers interested in prolonging the life of these cells ...
Researchers describe one mechanism that favors rejection in transplantation of porcine cartilage in humans
1 hour ago
Researchers at the Bellvitge Institute of Biomedical Research (IDIBELL) led by Cristina Costa from the New Therapies on Genes and Transplantation group have shown that inhibition of one of the basic components of the complement ...
Supercomputing human immunology
2 hours ago
Larry Smarr began his scientific career as an astrophysicist studying billions of stars in far-off galaxies. More recently, he's been studying much larger numbers of units closer to home—his own body.
Nanotherapeutic that can cross blood-brain barrier
3 hours ago
The University of Delaware's Emily Day is a part of a team of researchers that has developed a nanotherapeutic capable of penetrating the blood-brain barrier.
User comments
© Medical Xpress 2011-2013, Phys.org network
The resistance of some cancers to the cell-killing effects of radiation therapy may be due to abnormalities in the mitochondria – the cellular structures responsible for generating energy, according to an international team of researchers. Their findings are published in the Nov. 25 issue of Developmental Cell.
Maxim Frolov, associate professor of biochemistry and molecular genetics at the University of Illinois at Chicago, and colleagues investigated the effects of a mutation in a gene called E2F, which controls other genes responsible for initiating programmed cell death, a normal function in most cells. Cells undergo programmed cell death—or apoptosis—when they are no longer needed, as a normal part of aging, or in response to environmental factors like radiation that damage cellular DNA.
When Frolov and colleagues exposed fruit flies carrying a mutant E2F gene to radiation, genes that initiate apoptosis were activated, but the flies did not die.
"Something else was preventing the flies from dying, even though the genes needed to undergo cell death were turned on," Frolov said.
A closer look within the cells of the flies revealed that their mitochondria were misshapen and produced less energy than normal mitochondria. Flies with the most severely deranged mitochondria were the most resistant to radiation-induced cell death.
The observation in fruit flies suggested a previously unknown role for the E2F transcription factor—the protein encoded by E2F that regulates expression of other genes—in mitochondrial function.
"It seems their mitochondria were also affected by the E2F mutation and were not functioning at full strength," said Frolov. "You need properly functioning mitochondria to carry out programmed cell death."
Turning to human cells, the researchers found the same effects: those that lacked the E2F gene were resistant to the effects of radiation. Frolov said the similarity in the findings shows that basic cellular functions do not change much across the vast evolutionary distance between fruit flies and humans.
"This result highlights a remarkable degree of conservation between fruit flies and humans and illustrates the advantages of using model organisms in cancer research," said Frolov, whose laboratory is part of the UIC Cancer Center.
Frolov and his colleagues think that dysfunctional mitochondria might underlie the differences in how patients respond to radiation therapy. Previous studies have suggested that the inability of some patients' mitochondria to support apoptosis might account for differences in their response to chemotherapy for acute myelogenous leukemia.
"If we could develop a small-molecule drug that could enhance mitochondrial function in these patients, we may be able to improve the effectiveness of radiation therapy," Frolov said.
Explore further: Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin
Medical Xpress on facebook
Related Stories
Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin
Nov 01, 2013
A new study from MIT and the University of Toronto offers a possible way to overcome that resistance. The researchers found that when cisplatin was delivered to cellular structures called mitochondria. DNA ...
Two pathways in the cell interact to spur tumor growth: study
Mar 28, 2011
Inactivation of two pathways that regulate cell division profoundly disrupts cell-cycle control and leads to tumor growth, according to researchers from the University of Illinois at Chicago College of Medicine.
How mitochondrial DNA defects cause inherited deafness
Feb 17, 2012
(Medical Xpress) -- Yale scientists have discovered the molecular pathway by which maternally inherited deafness appears to occur: Mitochondrial DNA mutations trigger a signaling cascade, resulting in programmed ...
'Jekyll-and-Hyde' protein offers a new route to cancer drugs
Sep 26, 2013
The mood changes of a 'Jekyll-and-Hyde' protein, which sometimes boosts tumour cell growth and at other times suppresses it, have been explained in a new study led by Oxford University researchers.
Mitochondrial cooperatives
Aug 13, 2013
Mitochondria, the organelles that supply the cell with energy, are highly dynamic and can link up to form complex tubular networks. A new study shows that this response can transiently compensate for a shortfall in energy ...
Recommended for you
Co-transplanted cells and treadmill training aids rats with spinal cord injury
14 minutes ago
After Schwann cells (SCs), the principal cells in the peripheral nervous system, and olfactory ensheathing cells (OECs), cells that ensheath the non-myelinated peripheral neurons in the nose, were co-transplanted into laboratory ...
Study shows marijuana's potential for treating autoimmune disorders
16 minutes ago
A new study from researchers at the University of South Carolina provides evidence that THC (tetrahydrocannabinol), a principal ingredient in marijuana, may be beneficial in treating those with autoimmune disorders.
EPC secreted factors favorably impact on pancreatic islet cell cotransplantation
17 minutes ago
Pancreatic islet transplantation is a promising therapy for treating type 1 diabetes, but the majority of transplanted cells die soon after they are transplanted. Researchers interested in prolonging the life of these cells ...
Researchers describe one mechanism that favors rejection in transplantation of porcine cartilage in humans
1 hour ago
Researchers at the Bellvitge Institute of Biomedical Research (IDIBELL) led by Cristina Costa from the New Therapies on Genes and Transplantation group have shown that inhibition of one of the basic components of the complement ...
Supercomputing human immunology
2 hours ago
Larry Smarr began his scientific career as an astrophysicist studying billions of stars in far-off galaxies. More recently, he's been studying much larger numbers of units closer to home—his own body.
Nanotherapeutic that can cross blood-brain barrier
3 hours ago
The University of Delaware's Emily Day is a part of a team of researchers that has developed a nanotherapeutic capable of penetrating the blood-brain barrier.
User comments
© Medical Xpress 2011-2013, Phys.org network
0 comments:
Post a Comment